| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8787632 | Journal of Thoracic Oncology | 2018 | 11 Pages |
Abstract
This study provides further evidence that IL1B promoter polymorphisms may modulate the risk for development of lung cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Keith D. MD, PhD, Perrin E. MD, MSc, Gary E. MD, MS, Mark D. PhD, Matt J. MS, Effie W. MD,